Viewing Study NCT01982058


Ignite Creation Date: 2025-12-24 @ 11:59 PM
Ignite Modification Date: 2026-01-04 @ 1:30 AM
Study NCT ID: NCT01982058
Status: COMPLETED
Last Update Posted: 2022-10-19
First Post: 2013-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
Sponsor: Rutgers, The State University of New Jersey
Organization:

Study Overview

Official Title: Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
Status: COMPLETED
Status Verified Date: 2022-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners.

PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.
Detailed Description: Aim 1 A. To evaluate the impact of an Intimacy-Enhancing Couples' intervention (IEC) versus a General Health and Wellness Intervention (GHW) and a Usual care control (UC) on patient and partner psychological and relationship outcomes.

B. To determine whether relationship length, pre-intervention relationship satisfaction, and men's pre-intervention masculinity moderate the effects of IEC on couples' psychological and relationship outcomes

Aim 2 A. To evaluate whether IEC has an effect on couples' communication and intimacy when compared with GHW and UC and to determine whether changes in relationship communication and intimacy mediate changes in couples' psychological and relationship outcomes.

Exploratory Aim:

A. To evaluate the impact of IEC versus GHW on physical activity and fruit and vegetable intake as well as each partner's support for the other partner's adoption of greater physical activity and more fruit and vegetable intake.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
0220100274 OTHER IRB number View
NCI-2012-00552 OTHER CTRP (Clinical Trails Reporting Program) View
131023 OTHER Rutgers Cancer Institute of New Jersey View